Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The price of Inspire Medical Systems Inc (NYSE: INSP) closed at $241.15 in the last session, down -0.97% from day before closing price of $243.51. In other words, the price has decreased by -$0.97 from its previous closing price. On the day, 0.88 million shares were traded. INSP stock price reached its highest trading level at $250.68 during the session, while it also had its lowest trading level at $237.1943.
Ratios:
We take a closer look at INSP’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 15.87 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7163.57. For the most recent quarter (mrq), Quick Ratio is recorded 7.17 and its Current Ratio is at 7.60. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on March 19, 2024, initiated with a Overweight rating and assigned the stock a target price of $250.
On January 19, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $245.Jefferies initiated its Buy rating on January 19, 2024, with a $245 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 17 ’24 when Buchholz Richard sold 15,000 shares for $230.03 per share. The transaction valued at 3,450,450 led to the insider holds 28,271 shares of the business.
Herbert Timothy P. sold 40,000 shares of INSP for $8,203,581 on Apr 01 ’24. The CEO and President now owns 63,658 shares after completing the transaction at $205.09 per share. On Apr 01 ’24, another insider, Griffin Jerry C, who serves as the Director of the company, sold 32 shares for $213.99 each. As a result, the insider received 6,848 and left with 10,900 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INSP now has a Market Capitalization of 7306193920 and an Enterprise Value of 6698918912. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.69 while its Price-to-Book (P/B) ratio in mrq is 12.45. Its current Enterprise Value per Revenue stands at 10.722 whereas that against EBITDA is -178.996.
Stock Price History:
Over the past 52 weeks, INSP has reached a high of $330.00, while it has fallen to a 52-week low of $123.27. The 50-Day Moving Average of the stock is 19.09%, while the 200-Day Moving Average is calculated to be 17.71%.
Shares Statistics:
According to the various share statistics, INSP traded on average about 502.54K shares per day over the past 3-months and 634530 shares per day over the past 10 days. A total of 30.30M shares are outstanding, with a floating share count of 29.65M. Insiders hold about 2.14% of the company’s shares, while institutions hold 102.69% stake in the company. Shares short for INSP as of 1711584000 were 2079086 with a Short Ratio of 4.14, compared to 1709164800 on 1748508. Therefore, it implies a Short% of Shares Outstanding of 2079086 and a Short% of Float of 7.8600004000000006.
Earnings Estimates
The market rating for Inspire Medical Systems Inc (INSP) is a result of the insights provided by Inseego Corp. analysts actively involved in the assessment.The consensus estimate for the next quarter is $24.80, with high estimates of $1.81 and low estimates of $241.15.
Analysts are recommending an EPS of between $Healthcare and $Healthcare for the fiscal current year, implying an average EPS of $Healthcare.
